Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,892 | 10,145 | 10,863 | 9,601 | 8,691 |
| Receivables | 83 | 82 | 78 | 77 | 54 |
| TOTAL | $11,755 | $11,043 | $11,862 | $10,153 | $9,240 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 27 | 3 | 3 | 3 | 3 |
| TOTAL | $27 | $3 | $3 | $3 | $3 |
| Total Assets | $11,782 | $11,046 | $11,865 | $10,155 | $9,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,176 | 1,723 | 1,841 | 1,512 | 1,152 |
| Accrued Expenses | 6,819 | 3,321 | 3,216 | 2,318 | 2,457 |
| TOTAL | $9,994 | $5,044 | $5,058 | $3,830 | $3,609 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,746 | 2,125 | 1,865 | 2,691 | 4,015 |
| TOTAL | $1,746 | $2,125 | $1,865 | $2,691 | $4,015 |
| Total Liabilities | $11,740 | $7,169 | $6,922 | $6,521 | $7,624 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,032 | 32,993 | 30,307 | 29,587 | 25,332 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -106,002 | -97,099 | -91,752 | -87,235 | -83,663 |
| Other shareholders' equity | -31 | -30 | -38 | -31 | -12 |
| TOTAL | $42 | $3,877 | $4,943 | $3,635 | $1,619 |
| Total Liabilities And Equity | $11,782 | $11,046 | $11,865 | $10,155 | $9,243 |